Format

Send to

Choose Destination
Oncogene. 2014 May 15;33(20):2557-67. doi: 10.1038/onc.2013.216. Epub 2013 Jun 3.

MicroRNA-29c functions as a tumor suppressor by direct targeting oncogenic SIRT1 in hepatocellular carcinoma.

Author information

1
1] Laboratory of Oncogenomics, Department of Pathology, College of Medicine, Catholic University of Korea, Seoul, Republic of Korea [2] Functional RNomics Research Center, Catholic University of Korea, Seoul, Republic of Korea.
2
1] Laboratory of Oncogenomics, Department of Pathology, College of Medicine, Catholic University of Korea, Seoul, Republic of Korea [2] Functional RNomics Research Center, Catholic University of Korea, Seoul, Republic of Korea [3] Cancer Evolution Research Center, Catholic University of Korea, Seoul, Republic of Korea.

Abstract

Mammalian sirtuin 1 (SIRT1) has connected to an ever widening circle of activities that encompass cellular stress resistance, energy metabolism and tumorigenesis. However, underlying mechanisms leading to oncogenic SIRT1 overexpression are less understood. In this study, we identified SIRT1 regulatory microRNA (miRNA) and its function in hepatocellular carcinoma (HCC). Aberrant SIRT1 overexpression was demonstrated in a subset of human HCCs. SIRT1 knockdown suppressed HCC cell growth by transcriptional deregulation of cell cycle proteins. This led to hypophosphorylation of pRb, which inactivated E2F/DP1 target gene transcription, and thereby caused significant increase of HCC cells to remain in the G1/S phase. A comprehensive miRNA profiling analysis indentified five putative endogenous miRNAs that are significantly downregulated in HCC. Ectopic expression of miRNA mimics evidenced miR-29c to suppress SIRT1 in HCC cells. Notably, ectopic miR-29c expression repressed cancer cell growth and proliferation, and it recapitulated SIRT1 knockdown effects in HCC cells. In addition, miR-29c expression was downregulated in a large cohort of HCC patients, and low expression of miR-29c was significantly associated with poor prognosis of HCC patients. Taken together, we demonstrated that miR-29c suppresses oncogenic SIRT1 by way of binding to 3'-untranslated region of SIRT1 mRNA causing translational inhibition in liver cancer cells. The loss or suppression of miR-29c may cause aberrant SIRT1 overexpression and promotes liver tumorigenesis. Overall, we suggest that miR-29c functions as a tumor suppressor by regulating abnormal SIRT1 activity in liver.

PMID:
23728341
DOI:
10.1038/onc.2013.216
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Nature Publishing Group
Loading ...
Support Center